Product Program year 2022 Source: CMS Open Payments

Dsuvia

Drug Pain Management

NDC 61621-430-11

Open in the dashboard

General payments

$2,030,395

6,264 payments

Research payments

$529,663

26 payments

Through program year 2022, $2,030,395 in general payments and $529,663 in research payments were reported against Dsuvia (Pain Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2022 General $406,130 803
2022 Research $153,300 8
2021 General $439,759 2,141
2021 Research $261,989 11
2020 General $518,995 1,588
2020 Research $109,375 6
2019 General $665,511 1,732
2019 Research $5,000 1

Breakdown

Who paid General payments · program years 2019–2022
  1. AcelRx Pharmaceuticals, Inc. $2,030,265 6,261 payments
  2. Tetraphase Pharmaceuticals, Inc. $130 3 payments
Top recipients General payments · program year 2022
  1. Talon Maningas Otolaryngology · Joplin, MO $305,400 75% · 4 payments
  2. David Rapaport Plastic Surgery · New York, NY $8,883 2% · 10 payments
  3. Ashley Sikand Otolaryngology · Henderson, NV $6,750 2% · 4 payments
  4. Hisham Seify Plastic and Reconstructive Surgery · Newport Beach, CA $6,715 2% · 5 payments
  5. Brian Weeks Otolaryngology · San Diego, CA $6,250 2% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Otolaryngology $337,068 83% · 39 practitioners
  2. Anesthesiology $18,683 5% · 44 practitioners
  3. Plastic Surgery $15,208 4% · 66 practitioners
  4. Plastic and Reconstructive Surgery Surgery $7,866 2% · 39 practitioners
  5. Facial Plastic Surgery Otolaryngology $3,924 <1% · 10 practitioners

The top 5 of 69 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Missouri $305,451 75% · 4 recipients
  2. California $31,423 8% · 74 recipients
  3. New York $16,023 4% · 83 recipients
  4. Texas $14,376 4% · 52 recipients
  5. Michigan $9,238 2% · 16 recipients

The top 5 of 44 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

6,264 general · 26 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record